Search Results

ML281 50mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

ML281 5mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

ML281 10mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

ML281 25mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

ML281 100mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

ML281 250mg  | ≥99%

CSNpharm

ML281 is a potent and selective serine/threonine kinase (STK33) inhibitor with IC50 of 14 nM. STK33 downregulation is toxic to KRAS-dependent cancer cell lines.

More Information Supplier Page

Elbasvir 1mg  | ≥99%

CSNpharm

Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV). It can be used to treat chronic HCV infection.

More Information Supplier Page

Elbasvir 10mg  | ≥99%

CSNpharm

Elbasvir is an inhibitor of nonstructural protein 5A (NS5A) of hepatitis C virus (HCV). It can be used to treat chronic HCV infection.

More Information Supplier Page